P/E ratio for MannKind Corp (MNKD)

P/E ratio history for MannKind Corp from 2004 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Pfizer PFE	20.3	-38.02%	🇺🇸 USA
Novo Nordisk NVO	10.7	-67.50%	🇩🇰 Denmark
Eli Lilly LLY	45.7	39.33%	🇺🇸 USA
Merck MRK	16.9	-48.34%	🇺🇸 USA
Halozyme Therapeutics HALO	14.2	-56.65%	🇺🇸 USA
Nektar Therapeutics NKTR	-8.65	-126.39%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.